Losartan Potassium and Hydrochlorothiazide Tablets — Class II drug recall D-1500-2014
Terminated recall by Jubilant Cadista Pharmaceuticals Inc., reported 2014-08-06, distributed nationwide. Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
| Recall number | D-1500-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD, United States |
| Recall initiated | 2014-07-11 |
| Classified | 2014-07-31 |
| Reported by FDA | 2014-08-06 |
| Terminated | 2016-09-15 |
| Distributed | Nationwide (US) |
| Quantity | 9,358 bottles |
| NDC | 59746-0337, 59746-0337-01, 59746-0337-10, 59746-0337-30, 59746-0337-90, 59746-0338, 59746-0338-01, 59746-0338-10, 59746-0338-30, 59746-0338-90, 59746-0339, 59746-0339-01, 59746-0339-10, 59746-0339-30, 59746-0339-90 |
| Lot numbers | 14P0292 |
| Expiration dates | 2016-04 |
Product
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90
Reason for recall
Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1500-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.